"multiplexed droplet digital nucleic acid amplification technologies for HIV diagnosis"
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93023C00008
- Awardee
-
Vivid Bioinnovations, PBC UEI Q1NZN4P95F83
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,903
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · SBIRPHS20231 · Posted Jul 20, 2022
- Contract value 100% obligated
- $299,903.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 9 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Francisco, CA 94107, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services, National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase I contract to Fluid Discovery, Inc., a for-profit small business, to develop "Multiplexed Droplet Digital Nucleic Acid Amplification Technologies for HIV Diagnosis." The $299,903 firm-fixed-price contract, which runs through July 31, 2024, supports research and development of innovative diagnostic methods to advance NIH's mission related to HIV/AIDS. This contract was set aside for small businesses and aligns with the SBIR program's goals of stimulating technological innovation and strengthening the role of small businesses in meeting federal research needs.
Quick answers
Who was awarded contract 75N93023C00008?
75N93023C00008 was awarded to Vivid Bioinnovations, PBC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2023.
How much is contract 75N93023C00008 worth?
The government has obligated $299,903 on 75N93023C00008.
Was contract 75N93023C00008 competed?
The extent of competition for 75N93023C00008 was full and open competition after exclusion of sources. The government received 9 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award